Knight Cancer Challenge anniversary
December 15, 2025
Jackie Shannon, Ph.D., speaks about the importance of cancer research. Celebrating a decade of groundbreaking achievements in cancer research, care, and prevention, OHSU honors the legacy of the Knight Cancer Challenge with a special dinner and panel discussion at the Robertson Life Sciences Building. (OHSU)
Knight Cancer Challenge
December 15, 2025
Brandon Hayes-Lattin, M.D., speaks about cancer and cancer research. Celebrating a decade of groundbreaking achievements in cancer research, care, and prevention, OHSU honors the legacy of the Knight Cancer Challenge with a special dinner and panel discussion at the Robertson Life Sciences Building. From left: Shivani Kumar, Ph.D., Jose Luis Montoya Mira, Ph.D., Hayes-Lattin, Jackie Shannon, Ph.D., and Rosalie Sears, Ph.D. (OHSU)
Paciente de OHSU enfrenta un cáncer colorrectal durante su preparación para la Maratón de Boston
December 12, 2025
Gracias a la atención personalizada y multidisciplinaria recibida en OHSU, Matt Hazard logró superar el cáncer e inspirar a otras personas a realizarse colonoscopías.
OHSU patient battles colorectal cancer on journey to Boston Marathon
December 12, 2025
Matt Hazard received personalized, multidisciplinary care at OHSU that allowed him to overcome cancer, inspire others to get colonoscopies.
OHSU emphasizes crucial role of vaccines, including hepatitis B, for babies
December 11, 2025
Amid changes in federal recommendations, pediatric health experts remind community members of the safety, efficacy of routine childhood vaccines.
Study implicates enzyme in neurodegenerative conditions
December 11, 2025
OHSU research finds a specific enzyme is involved in myelin breakdown that causes conditions such as MS, stroke, Alzheimer’s.
Estudio de OHSU: La terapia CAR-T muestra supervivencia a largo plazo para pacientes con linfoma
December 11, 2025
Los datos de cinco años de un ensayo clínico para adultos con linfoma de células B grandes recidivante o refractario confirman remisiones duraderas en pacientes de alto riesgo.
OHSU study: CAR-T therapy shows long-term survival for patients with lymphoma
December 11, 2025
Five-year data from clinical trial for adults with relapsed or refractory large B-cell lymphoma confirms lasting remissions in high-risk patients.
OHSU selects health system chief executive officer, executive vice president
November 24, 2025
Announcement from Shereef Elnahal, M.D., M.B.A.
